vs

Side-by-side financial comparison of LSI INDUSTRIES INC (LYTS) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $143.9M, roughly 1.4× LSI INDUSTRIES INC). REPLIGEN CORP runs the higher net margin — 6.7% vs 1.4%, a 5.3% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs -4.4%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 2.1%).

LSI Logic Corporation was an American ASIC and EDA company founded in Santa Clara, California. The company designed and sold semiconductors and software that accelerated storage and networking in data centers, mobile networks and client computing.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

LYTS vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.4× larger
RGEN
$197.9M
$143.9M
LYTS
Growing faster (revenue YoY)
RGEN
RGEN
+18.0% gap
RGEN
13.6%
-4.4%
LYTS
Higher net margin
RGEN
RGEN
5.3% more per $
RGEN
6.7%
1.4%
LYTS
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
2.1%
LYTS

Income Statement — Q1 FY2027 vs Q4 FY2025

Metric
LYTS
LYTS
RGEN
RGEN
Revenue
$143.9M
$197.9M
Net Profit
$2.0M
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
1.4%
6.7%
Revenue YoY
-4.4%
13.6%
Net Profit YoY
-4.8%
143.9%
EPS (diluted)
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LYTS
LYTS
RGEN
RGEN
Q3 26
$143.9M
Q1 26
$143.9M
Q4 25
$147.0M
$197.9M
Q3 25
$157.2M
$188.8M
Q2 25
$155.1M
$182.4M
Q1 25
$132.5M
$169.2M
Q4 24
$147.7M
$174.1M
Q3 24
$138.1M
$154.9M
Net Profit
LYTS
LYTS
RGEN
RGEN
Q3 26
$2.0M
Q1 26
$2.0M
Q4 25
$6.3M
$13.3M
Q3 25
$7.3M
$14.9M
Q2 25
$8.2M
$14.9M
Q1 25
$3.9M
$5.8M
Q4 24
$5.6M
$-30.3M
Q3 24
$6.7M
$-654.0K
Gross Margin
LYTS
LYTS
RGEN
RGEN
Q3 26
Q1 26
Q4 25
25.5%
52.5%
Q3 25
25.6%
53.2%
Q2 25
26.1%
50.0%
Q1 25
24.8%
53.6%
Q4 24
23.6%
26.1%
Q3 24
24.4%
50.0%
Operating Margin
LYTS
LYTS
RGEN
RGEN
Q3 26
Q1 26
Q4 25
6.0%
9.0%
Q3 25
7.0%
8.9%
Q2 25
7.7%
7.6%
Q1 25
4.7%
3.9%
Q4 24
5.7%
-17.7%
Q3 24
6.6%
-5.1%
Net Margin
LYTS
LYTS
RGEN
RGEN
Q3 26
1.4%
Q1 26
1.4%
Q4 25
4.3%
6.7%
Q3 25
4.6%
7.9%
Q2 25
5.3%
8.2%
Q1 25
2.9%
3.4%
Q4 24
3.8%
-17.4%
Q3 24
4.8%
-0.4%
EPS (diluted)
LYTS
LYTS
RGEN
RGEN
Q3 26
Q1 26
Q4 25
$0.20
$0.24
Q3 25
$0.23
$0.26
Q2 25
$0.26
$0.26
Q1 25
$0.13
$0.10
Q4 24
$0.18
$-0.55
Q3 24
$0.22
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LYTS
LYTS
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$767.6M
Total DebtLower is stronger
$261.0M
$542.2M
Stockholders' EquityBook value
$352.8M
$2.1B
Total Assets
$800.5M
$2.9B
Debt / EquityLower = less leverage
0.74×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LYTS
LYTS
RGEN
RGEN
Q3 26
Q1 26
Q4 25
$6.4M
$767.6M
Q3 25
$7.1M
$748.7M
Q2 25
$3.5M
$708.9M
Q1 25
$4.3M
$697.2M
Q4 24
$4.7M
$757.4M
Q3 24
$7.0M
$784.0M
Total Debt
LYTS
LYTS
RGEN
RGEN
Q3 26
$261.0M
Q1 26
$261.0M
Q4 25
$27.9M
$542.2M
Q3 25
$50.7M
$537.9M
Q2 25
$48.6M
Q1 25
$55.4M
Q4 24
$38.2M
$525.6M
Q3 24
$47.7M
Stockholders' Equity
LYTS
LYTS
RGEN
RGEN
Q3 26
$352.8M
Q1 26
$352.8M
Q4 25
$248.1M
$2.1B
Q3 25
$241.3M
$2.1B
Q2 25
$230.7M
$2.1B
Q1 25
$221.7M
$2.0B
Q4 24
$217.1M
$2.0B
Q3 24
$211.2M
$2.0B
Total Assets
LYTS
LYTS
RGEN
RGEN
Q3 26
$800.5M
Q1 26
$800.5M
Q4 25
$396.3M
$2.9B
Q3 25
$404.9M
$2.9B
Q2 25
$396.4M
$2.9B
Q1 25
$384.6M
$2.9B
Q4 24
$344.5M
$2.8B
Q3 24
$349.5M
$2.8B
Debt / Equity
LYTS
LYTS
RGEN
RGEN
Q3 26
0.74×
Q1 26
0.74×
Q4 25
0.11×
0.26×
Q3 25
0.21×
0.26×
Q2 25
0.21×
Q1 25
0.25×
Q4 24
0.18×
0.27×
Q3 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LYTS
LYTS
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LYTS
LYTS
RGEN
RGEN
Q3 26
Q1 26
Q4 25
$25.0M
$25.7M
Q3 25
$676.0K
$48.1M
Q2 25
$9.5M
$28.6M
Q1 25
$6.9M
$15.0M
Q4 24
$9.9M
$39.2M
Q3 24
$11.8M
$49.3M
Free Cash Flow
LYTS
LYTS
RGEN
RGEN
Q3 26
Q1 26
Q4 25
$23.3M
$17.6M
Q3 25
$-291.0K
$43.4M
Q2 25
$8.5M
$21.5M
Q1 25
$6.2M
$11.4M
Q4 24
$8.8M
$33.6M
Q3 24
$11.1M
$42.3M
FCF Margin
LYTS
LYTS
RGEN
RGEN
Q3 26
Q1 26
Q4 25
15.8%
8.9%
Q3 25
-0.2%
23.0%
Q2 25
5.5%
11.8%
Q1 25
4.7%
6.8%
Q4 24
6.0%
19.3%
Q3 24
8.0%
27.3%
Capex Intensity
LYTS
LYTS
RGEN
RGEN
Q3 26
Q1 26
Q4 25
1.1%
4.1%
Q3 25
0.6%
2.5%
Q2 25
0.6%
3.9%
Q1 25
0.5%
2.1%
Q4 24
0.7%
3.2%
Q3 24
0.5%
4.5%
Cash Conversion
LYTS
LYTS
RGEN
RGEN
Q3 26
Q1 26
Q4 25
3.94×
1.93×
Q3 25
0.09×
3.23×
Q2 25
1.16×
1.92×
Q1 25
1.77×
2.57×
Q4 24
1.75×
Q3 24
1.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons